UBS Group AG - DOVA PHARMACEUTICALS INC ownership

DOVA PHARMACEUTICALS INC's ticker is DOVA and the CUSIP is 25985T102. A total of 68 filers reported holding DOVA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of DOVA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$1,622,000
+13416.7%
58,035
+6776.2%
0.00%
Q2 2019$12,000
+300.0%
844
+181.3%
0.00%
Q1 2019$3,000
-78.6%
300
-83.6%
0.00%
Q4 2018$14,000
-70.8%
1,834
-19.5%
0.00%
Q3 2018$48,000
+60.0%
2,279
+127.9%
0.00%
Q2 2018$30,000
+1400.0%
1,000
+963.8%
0.00%
Q3 2017$2,000
-96.4%
94
-96.2%
0.00%
Q2 2017$56,0002,5000.00%
Other shareholders
DOVA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Perceptive Advisors 3,125,851$23,693,0000.90%
Broadfin Capital, LLC 351,800$2,667,0000.35%
Birchview Capital, LP 40,000$303,0000.29%
SPHERA FUNDS MANAGEMENT LTD. 185,000$1,402,0000.16%
Fosun International Ltd 261,780$1,984,0000.12%
Spark Investment Management LLC 61,100$463,0000.03%
Candriam S.C.A. 233,200$1,768,0000.03%
GW&K Investment Management, LLC 178,536$1,353,0000.03%
Tower Research Capital LLC (TRC) 20,613$156,0000.01%
Point72 Hong Kong Ltd 1,456$11,0000.01%
View complete list of DOVA PHARMACEUTICALS INC shareholders